Beverage business The Calmer Co International (ASX: CCO) has delivered its strongest single-month performance since listing on the Australian Securities Exchange in 2018, with unaudited sales of $910,767 in December.
The company’s wholesale channel recorded its strongest monthly revenue of $340,131, with year-to-date sales already exceeding the total annual wholesale revenue recorded in financial year 2025.
The Calmer Co has reported continued sales momentum across all channels including Australian grocery, US Amazon and B2B ingredients.
The record performance reflects continued improvement in channel mix and margin profile, supporting The Calmer Co’s path toward sustainable profitability.
Broad-Based Strength
Australian retail performance has remained strong, led by distribution and sales of Fiji Kava through the Coles and Woolworths networks.
US sales growth has been driven by an expanding Amazon product range, following the US Food and Drug Administration’s recent ++landmark confirmation++ that traditionally-brewed kava beverages qualify as food under federal law.
Other product formats including tinctures (concentrated liquid extracts), capsules, and flavoured kava shots continue to sit within the dietary supplement framework, aligning with The Calmer Co’s multi-format portfolio strategy and strengthening its ability to scale in the US market.
Increased demand for high-kavalactone kava extracts from global partners has supported B2B ingredient sales.
Journey to Profitability
Founder and chief executive officer Zane Yoshida said the results further underpin the company’s journey towards break-even and profitability.
“Achieving our highest ever monthly revenue is a defining milestone for us and clearly demonstrates accelerating global demand for high-quality, traceable kava ingredients,” he said.
“With over 21 million Americans now consuming kava, we believe our expanding US portfolio of dietary supplement formats combined with the strength of our Australian grocery footprint and accelerating wholesale demand positions us for sustained and profitable growth this financial year.”
The Calmer Co’s products are available to consumers globally through e-commerce channels and bluechip retail partners, supported by a robust farm-to-shelf supply chain.
The range includes drinking powders, natural and flavoured kava shots and concentrates, and capsules sold under the brands Fiji Kava, Taki Mai and Danodan Hempworks across markets including US, Australia, New Zealand, China, and the Pacific Islands.
